PILOT AND FEASIBILITY PROGRAM

试点和可行性(P&F)计划自1978年启动以来，已经资助了85个项目(包括2006个项目)。 这一方案非常有价值和有效，为糖尿病相关患者提供了资金支持 项目。该计划的目标是支持新研究人员(世卫组织)开展的小型研究项目 很少或没有独立的研究支持)或正在转向糖尿病的老牌研究人员 这是第一次进行研究。绝大多数提案都属于前一类。三个新项目 通常每年都会启动。在全校范围内征求建议书后，四名个人(两名 机构内部和两个外部)审查每一笔赠款。对这项建议的批评是通过以下方式进行评估的 P&F审查委员会(相当于NIH的一个研究部门)，每个提案都被分配了一个优先事项 得分。然后将提案和优先级分数提交给DRTC执行委员会(相当于 提交给美国国立卫生研究院理事会)，以便做出资金决定。对第二年研究的支持在以下情况下授予 令人满意的工作在第一年内完成，如果项目在 临时的。 这一项目的成功率，衡量的是仍参与其中的调查人员的数量 糖尿病研究，或将他们的P&F转化为国家奖励的、同行评审的赠款的人很高(75% 1996-2000年资助的赠款)。此外，该计划还为各种不同的应用程序提供资金 机构内部的部门。例如，来自医学系、分子系的教职员工 生理学和生物物理学、生物化学、生物医学工程、麻醉学、儿科学、细胞和 发育生物学、化学、护理和病理学在过去五年中获得资助。P&F 该计划还为DRTC在范德比尔特科学界提供了可见性，从而使 科学界更多地了解DRTC、其研究努力及其核心设施。它的重要性 VUMC领导层的决定突显了DRTC P&F计划的有效性 在下一个资金周期为该计划提供额外资金(10万美元)。

The Pilot and Feasibility (P&F) program has funded 85 projects (including 2006) since it inception in 1978. This program has been extremely valuable and effective by providing funds for the support of diabetesrelated projects. The goal of the program is to support small research projects by new investigators (who have little or no independent research support) or established investigators who are turning to diabetes research for the first time. The vast majority of the proposals are in the former category. Three new projects are normally initiated each year. After a university-wide solicitation of proposals, four individuals (two internal and two external to the institution) review each grant. The critiques of the proposal are evaluated by the P&F Review Committee (equivalent to an NIH study section), and each proposal is assigned a priority score. The proposals and priority scores are then presented to the DRTC Executive Committee (equivalent to the NIH Council) for a funding decision. Support for a second year of research is awarded when satisfactory work is completed in year one and if support for the projects has not been obtained in the interim. The success rate of this program, measured either by the number of investigators who remain involved in diabetes research, or who convert their P&F into a nationally awarded, peer-reviewed grant, is high (75% of grants funded from 1996-2000). In addition, this program funds applications from a wide variety of departments within the institution. For example, faculty members from Departments of Medicine, Molecular Physiology and Biophysics, Biochemistry, Biomedical Engineering, Anesthesia, Pediatrics, Cell and Developmental Biology, Chemistry, Nursing, and Pathology were funded over the past five years. The P&F program also provides visibility for the DRTC within the Vanderbilt scientific community and thus makes the scientific community more aware of the DRTC, its research efforts, and its core facilities. The importance and effectiveness of the DRTC P&F program is underscored by the decision of the VUMC leadership to provide additional funds ($100K) for this program in the next funding cycle.